BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Luo XJ, Tan WF, Yi B, Liu c, Jiang XQ, Zhang BH, Sheng F, Wu MC. Surgery of hepatocellular carcinoma complicated with cancer thrombi in bile duct: efficacy for criteria for different therapy modalities. Langenbecks Arch Surg. 2009;394:1033-1039. [PMID: 19421771 DOI: 10.1007/s00423-009-0496-6] [Cited by in Crossref: 35] [Cited by in F6Publishing: 31] [Article Influence: 2.7] [Reference Citation Analysis]
Number Citing Articles
1 Bai S, Wu Y, Yan Y, Li R, Kang H, Zhang J, Ma W, Gao Y, Hui B, Ma H, Zhang X, Ren J. Evaluation of the Efficacy and Toxicity of Radiotherapy for Type III-IV Portal Vein Tumor Thrombi. Technol Cancer Res Treat 2021;20:1533033821995286. [PMID: 33590809 DOI: 10.1177/1533033821995286] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
2 Wu JY, Sun JX, Wu JY, Huang XX, Bai YN, Zeng YY, Zhang ZB, Cheng SQ, Yan ML. A nomogram based on combining systemic and hepatic inflammation markers for predicting microscopic bile duct tumour thrombus in hepatocellular carcinoma. BMC Cancer 2021;21:272. [PMID: 33711965 DOI: 10.1186/s12885-021-07956-9] [Reference Citation Analysis]
3 Matsumura M, Seyama Y, Ishida H, Nemoto S, Tani K, Imamura J. Indocyanine green fluorescence navigation for hepatocellular carcinoma with bile duct tumor thrombus: a case report. Surg Case Rep 2021;7:18. [PMID: 33438064 DOI: 10.1186/s40792-020-01101-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Jang YR, Lee KW, Kim H, Lee JM, Yi NJ, Suh KS. Bile duct invasion can be an independent prognostic factor in early stage hepatocellular carcinoma. Korean J Hepatobiliary Pancreat Surg. 2015;19:167-172. [PMID: 26693236 DOI: 10.14701/kjhbps.2015.19.4.167] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
5 Chi Q, Shi Z, Zhang Z, Zhang X, Zhang L, Weng S. Outcomes of resection for hepatocellular carcinoma with macroscopic bile duct tumour thrombus: A propensity score matched study. Oncol Lett 2020;20:118. [PMID: 32863931 DOI: 10.3892/ol.2020.11979] [Reference Citation Analysis]
6 Huang Q, Chen Y, Lin K, Sun C, Zheng S, Chen J, Wang Y, Zhou Y, Zhou W, Liu J, Zeng Y. Redefining Hepatocellular Carcinoma Staging Systems Based on the Bile Duct Invasion Status: A Multicenter Study. Front Oncol 2021;11:673285. [PMID: 34722235 DOI: 10.3389/fonc.2021.673285] [Reference Citation Analysis]
7 Tan W, He J, Deng J, Yang X, Cui L, Ran R, Du G, Jiang X. Small molecule metabolite biomarkers for hepatocellular carcinoma with bile duct tumor thrombus diagnosis. Sci Rep 2018;8:3309. [PMID: 29459779 DOI: 10.1038/s41598-018-21595-4] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 2.5] [Reference Citation Analysis]
8 Yang X, Zhu Y, Zhao X, Li JH, Xu D, Jia HL, Zhang JB. The Prognostic Comparison Between Hepatocellular Carcinoma with Portal Vein Tumor Thrombus and Bile Duct Cancer Thrombus After Liver Resection. Cancer Manag Res 2020;12:12077-86. [PMID: 33262656 DOI: 10.2147/CMAR.S278777] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
9 Choi J, Ryu JK, Lee SH, Ahn DW, Hwang JH, Kim YT, Yoon YB, Han JK. Biliary drainage for obstructive jaundice caused by unresectable hepatocellular carcinoma: the endoscopic versus percutaneous approach. Hepatobiliary Pancreat Dis Int. 2012;11:636-642. [PMID: 23232636 DOI: 10.1016/s1499-3872(12)60237-9] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 1.9] [Reference Citation Analysis]
10 Feng JK, Chen ZH, Sun JX, Wu JY, Guo WX, Shi J, Wei YG, Zhou JY, Zhang ZB, Yan ML, Cheng SQ. Concurrent bile duct resection versus concomitant thrombectomy for hepatocellular carcinoma associated with bile duct tumor thrombus: a propensity score matching analysis. Ann Transl Med 2021;9:457. [PMID: 33850854 DOI: 10.21037/atm-20-6449] [Reference Citation Analysis]
11 Sun J, Wu J, Liu C, Shi J, Wei Y, Zhou J, Zhang Z, Lau WY, Yan M, Cheng S. Typing of biliary tumor thrombus influences the prognoses of patients with hepatocellular carcinoma. Cancer Biol Med 2021:j. [PMID: 34021538 DOI: 10.20892/j.issn.2095-3941.2020.0202] [Reference Citation Analysis]
12 Zhang W, Fang C, Liu H, Chen Y. FDG PET/CT Imaging of Hepatocellular Carcinoma With Bile Duct Tumor Thrombus. Clin Nucl Med 2019;44:130-2. [DOI: 10.1097/rlu.0000000000002406] [Cited by in Crossref: 3] [Article Influence: 1.0] [Reference Citation Analysis]
13 Ha TY, Hwang S, Moon DB, Ahn CS, Kim KH, Song GW, Jung DH, Park GC, Park HW, Park YH, Kang SH, Jung BH, Lee SG. Long-term survival analysis of liver transplantation for hepatocellular carcinoma with bile duct tumor thrombus. Transplant Proc 2014;46:774-7. [PMID: 24767346 DOI: 10.1016/j.transproceed.2013.10.053] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
14 Zhao Y, Fang Z, Luo J, Liu Q, Xu G, Pan H, Wei W, Yan Z. Evaluation of extrahepatic collateral arteries in hepatocellular carcinoma in three independent groups in a single center. Exp Ther Med 2015;10:2366-74. [PMID: 26668643 DOI: 10.3892/etm.2015.2822] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
15 Wu JY, Huang LM, Bai YN, Wu JY, Wei YG, Zhang ZB, Yan ML. Imaging Features of Hepatocellular Carcinoma With Bile Duct Tumor Thrombus: A Multicenter Study. Front Oncol 2021;11:723455. [PMID: 34804918 DOI: 10.3389/fonc.2021.723455] [Reference Citation Analysis]
16 Navadgi S, Chang CC, Bartlett A, McCall J, Pandanaboyana S. Systematic review and meta-analysis of outcomes after liver resection in patients with hepatocellular carcinoma (HCC) with and without bile duct thrombus. HPB (Oxford). 2016;18:312-316. [PMID: 27037199 DOI: 10.1016/j.hpb.2015.12.003] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 3.7] [Reference Citation Analysis]
17 Cho YY, Lee SH, Lee JW, Park JM, Ryu JK, Kim YT, Yoon CJ, Kim H. [Disappearance of intrahepatic bile duct hepatocellular carcinoma after endoscopic retrograde cholangiopancreatography and transarterial chemoinfusion: a case report]. Korean J Gastroenterol 2014;63:321-4. [PMID: 24870306 DOI: 10.4166/kjg.2014.63.5.321] [Reference Citation Analysis]
18 Liu QY, Lai DM, Liu C, Zhang L, Zhang WD, Li HG, Gao M. A special recurrent pattern in small hepatocellular carcinoma after treatment: Bile duct tumor thrombus formation. World J Gastroenterol 2011; 17(43): 4817-4824 [PMID: 22147984 DOI: 10.3748/wjg.v17.i43.4817] [Cited by in CrossRef: 11] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
19 Feng JK, Chen ZH, Wu YX, Wang K, Sun JX, Chai ZT, Guo WX, Shi J, Cheng SQ. Comparison of different surgical interventions for hepatocellular carcinoma with bile duct tumor thrombus: a systematic review and meta-analysis. Ann Transl Med 2020;8:1567. [PMID: 33437766 DOI: 10.21037/atm-20-3935] [Reference Citation Analysis]
20 Zeng H, Xu LB, Wen JM, Zhang R, Zhu MS, Shi XD, Liu C. Hepatocellular carcinoma with bile duct tumor thrombus: a clinicopathological analysis of factors predictive of recurrence and outcome after surgery. Medicine (Baltimore) 2015;94:e364. [PMID: 25569656 DOI: 10.1097/MD.0000000000000364] [Cited by in Crossref: 22] [Cited by in F6Publishing: 14] [Article Influence: 3.1] [Reference Citation Analysis]
21 Moon DB, Hwang S, Wang HJ, Yun SS, Kim KS, Lee YJ, Kim KH, Park YK, Xu W, Kim BW, Lee DS, Lee DH, Kim HJ, Lim JH, Choi JS, Park YH, Lee SG. Surgical outcomes of hepatocellular carcinoma with bile duct tumor thrombus: a Korean multicenter study. World J Surg 2013;37:443-51. [PMID: 23188531 DOI: 10.1007/s00268-012-1845-0] [Cited by in Crossref: 39] [Cited by in F6Publishing: 32] [Article Influence: 4.3] [Reference Citation Analysis]
22 Lu Z, Sun W, Wen F, Liang H, Shan M, Guo Q. Clinical application of percutaneous drainage in treating hepatocellular carcinoma with bile duct tumor thrombus. Contemp Oncol (Pozn). 2013;17:176-183. [PMID: 23788987 DOI: 10.5114/wo.2013.34622] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
23 Sun J, Wu J, Shi J, Liu C, Wei Y, Zhou J, Zhang Z, Yan M, Cheng S. Thrombus-First Surgery for Hepatocellular Carcinoma with Bile Duct Tumor Thrombus. J Gastrointest Surg 2021;25:1973-9. [PMID: 33078320 DOI: 10.1007/s11605-020-04813-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
24 Yazawa T, Ohta T, Ariizumi SI, Takahashi Y, Higuchi R, Yamamoto M. A staged approach with initial tumor thrombectomy followed by hepatectomy for icteric-type hepatocellular carcinoma: A case report. Int J Surg Case Rep 2019;64:1-5. [PMID: 31585354 DOI: 10.1016/j.ijscr.2019.09.030] [Reference Citation Analysis]
25 Choi J, Ryu JK, Lee SH, Hwang JH, Ahn DW, Kim YT, Yoon YB, Yoon CJ, Kang SG, Chung JW. Palliative treatment of unresectable hepatocellular carcinoma with obstructive jaundice using biliary drainage with subsequent transarterial chemoembolization. J Palliat Med 2013;16:1026-33. [PMID: 23888306 DOI: 10.1089/jpm.2013.0067] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 1.1] [Reference Citation Analysis]
26 Kim DS, Kim BW, Hatano E, Hwang S, Hasegawa K, Kudo A, Ariizumi S, Kaibori M, Fukumoto T, Baba H, Kim SH, Kubo S, Kim JM, Ahn KS, Choi SB, Jeong CY, Shima Y, Nagano H, Yamasaki O, Yu HC, Han DH, Seo HI, Park IY, Yang KS, Yamamoto M, Wang HJ. Surgical Outcomes of Hepatocellular Carcinoma With Bile Duct Tumor Thrombus: A Korea-Japan Multicenter Study. Ann Surg 2020;271:913-21. [PMID: 30216223 DOI: 10.1097/SLA.0000000000003014] [Cited by in Crossref: 11] [Cited by in F6Publishing: 15] [Article Influence: 5.5] [Reference Citation Analysis]
27 Lee KE, Kim CW, Kim MJ, Park J, Cho GM, Jang JW, Lee YS, Lee CD. [Massive bleeding hemobilia occurred in patient with hepatocellular carcinoma]. Korean J Gastroenterol 2013;61:46-9. [PMID: 23354350 DOI: 10.4166/kjg.2013.61.1.46] [Cited by in Crossref: 3] [Article Influence: 0.3] [Reference Citation Analysis]
28 Gao J, Zhang Q, Zhang J, Kong J, Wang S, Ding X, Ke S, Sun W. Radiofrequency Ablation of the Main Lesion of Hepatocellular Carcinoma and Bile Duct Tumor Thrombus as a Radical Therapeutic Alternative: Two Case Reports. Medicine (Baltimore) 2015;94:e1122. [PMID: 26166111 DOI: 10.1097/MD.0000000000001122] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
29 Peng N, Li L, Cai X, Tan S, Wu T. Liver stem/progenitor cells in the canals of Hering: cellular origin of hepatocellular carcinoma with bile duct tumor thrombi? Stem Cell Rev. 2010;6:579-584. [PMID: 20809255 DOI: 10.1007/s12015-010-9188-4] [Cited by in Crossref: 5] [Cited by in F6Publishing: 9] [Article Influence: 0.5] [Reference Citation Analysis]
30 Lu WP, Tang HW, Yang ZY, Jiang K, Chen YL, Lu SC. A proposed modification for the Barcelona Clinic Liver Cancer staging system: Adding bile duct tumor thrombus status in patients with hepatocellular carcinoma. Am J Surg 2020;220:965-71. [PMID: 32336518 DOI: 10.1016/j.amjsurg.2020.04.003] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
31 Yang T, Lin C, Zhai J, Shi S, Zhu M, Zhu N, Lu JH, Yang GS, Wu MC. Surgical resection for advanced hepatocellular carcinoma according to Barcelona Clinic Liver Cancer (BCLC) staging. J Cancer Res Clin Oncol. 2012;138:1121-1129. [PMID: 22402598 DOI: 10.1007/s00432-012-1188-0] [Cited by in Crossref: 50] [Cited by in F6Publishing: 53] [Article Influence: 5.0] [Reference Citation Analysis]
32 Qiao W, Yu F, Wu L, Li B, Zhou Y. Surgical outcomes of hepatocellular carcinoma with biliary tumor thrombus: a systematic review. BMC Gastroenterol. 2016;16:11. [PMID: 26822229 DOI: 10.1186/s12876-016-0427-2] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.7] [Reference Citation Analysis]
33 Pang YB, Zhong JH, Luo XL, Ou C, Guo Z, Xiang BD, Peng NF, Li LQ. Clinicopathological characteristics and liver stem cell marker expression in hepatocellular carcinoma involving bile duct tumor thrombi. Tumour Biol 2016;37:5879-84. [PMID: 26586401 DOI: 10.1007/s13277-015-4446-3] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
34 Pang HF, Qin H, Li PY, Zhu L, Lu XY, Xu SN, Zhao HZ, Zhao Q. Acute pancreatitis secondary to primary liver cancer with hemobilia: A case report and literature review. Shijie Huaren Xiaohua Zazhi 2012; 20(14): 1266-1269 [DOI: 10.11569/wcjd.v20.i14.1266] [Reference Citation Analysis]
35 Chen ZH, Feng JK, Sun JX, Wu JY, Guo WX, Shi J, Wei YG, Zhou JY, Zhang ZB, Yan ML, Cheng SQ. Postoperative adjuvant transarterial chemoembolization improves outcomes of hepatocellular carcinoma associated with bile duct tumor thrombus: a propensity score matching analysis. HPB (Oxford) 2021:S1365-182X(21)01625-7. [PMID: 34635434 DOI: 10.1016/j.hpb.2021.09.005] [Reference Citation Analysis]
36 Zhao J, Xie Y. Progress in research of hepatocellular carcinoma with tumor thrombus. Shijie Huaren Xiaohua Zazhi 2019; 27(20): 1239-1247 [DOI: 10.11569/wcjd.v27.i20.1239] [Reference Citation Analysis]
37 Yang X, Qiu Z, Ran R, Cui L, Luo X, Wu M, Tan WF, Jiang X. Prognostic importance of bile duct invasion in surgical resection with curative intent for hepatocellular carcinoma using PSM analysis. Oncol Lett. 2018;16:3593-3602. [PMID: 30127966 DOI: 10.3892/ol.2018.9108] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]